Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development ... - PipelineReview.com (press release)
Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development ... PipelineReview.com (press release), Spain - ... the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's... |
Original post: Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development ... - PipelineReview.com (press release) by ©2008 Google at alzheimers treatment - Google News
Blog tag: Alzheimers treatment
Technorati tag: Alzheimers treatment